Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Delta Air Lines, Inc. (DAL) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

Delta Air Lines, Inc.Trade
DENTSPLY SIRONA IncTrade

Price performance (Past 24H)

Key statistics

Delta Air Lines, Inc. vs DENTSPLY SIRONA Inc — how do they compare? Delta Air Lines, Inc. trades at $82.6 (market cap $54.56B), while DENTSPLY SIRONA Inc trades at $8.67 (market cap $1.70B). The key difference: Delta Air Lines, Inc. is far larger — about 32.1× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals — on Pluang, investors hold Delta Air Lines, Inc. for 97 Days and DENTSPLY SIRONA Inc for 72 Days on average.

DALXRAY
Market Cap
$54.56B$1.70B
Volume
6,532,7364,220,050
Sector
IndustrialsHealth
52-Week High
$93.66$14.68
52-Week Low
$55.65$8.52
Typical Hold Time
97 Days72 Days
Enterprise Value
$69.88B$3.78B
Dividend Yield
1.04%5.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Delta Air Lines, Inc.

Delta Air Lines (DAL) trades at $82.14, down 1.82% on the day, with a bearish technical signal despite strong fundamentals. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. DAL maintains solid profitability with 5.78% net margin and 20.12% ROE, while trading at attractive valuations with P/E of 13.76 and P/S of 0.8. Recent news highlights competitive pressures from United and American's customer poaching efforts and Delta's decision to use Amazon's internet service over Starlink.

DAL presents a compelling value opportunity with strong analyst support (82% buy ratings) and 26% upside to consensus target of $103.36. However, near-term risks include fuel cost volatility, competitive threats to premium customers, and execution challenges. The improving cash flow trend with $1.08B net cash generation in 2025 supports dividend sustainability and operational flexibility.

DENTSPLY SIRONA Inc

DENTSPLY SIRONA (XRAY) trades at $8.69, near its 52-week low, with bearish technical signals and declining revenue trends. The company reported Q2 2026 earnings beat but faces margin pressure and negative profitability metrics. Recent news highlights institutional stake increases and ongoing restructuring efforts amid challenging dental market conditions.

The stock presents a high-risk opportunity with analyst consensus target of $13.40 suggesting 54% upside potential. However, persistent net losses, declining revenue, and bearish technical indicators warrant caution. Recovery depends on successful execution of turnaround initiatives and market share stabilization in competitive dental equipment sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DAL
76% Buy24% Sell
Avg holding period · 97 Days
XRAY

No sentiment data available yet.

Top news

Latest headlines on both assets

About Delta Air Lines, Inc.

Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke system network, where it gathers and distributes passengers across the globe through key locations such as Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta's sale of frequent flier miles, particularly to American Express, is a major driver of the firm's profits.

Read more on DAL →

About DENTSPLY SIRONA Inc

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters

Read more on XRAY →